Diabetes in rural South Africa- An assessment of care and complications by Rotchford, AP & Rotchford, KM
1m 
ORIGINAL ARTICLES 
Table V. Incidence of ventricular arrhythmia events at baseline, 3 
months, and at end of study (number of patients) 
VPB < 10/hour 
Baseline 
3 months 
VPB 10- 30/hour 
Baseline 
3 months 

































VPB = ventricular premature beats; VT ventricular tachycardia. 
thiazide dose from 12.5 to 25 mg daily did not have any 
additional significant effect on BP, but worsened the 
hypokalaemla. Therefore, based on these results, indapamide 
may be an appropriate choice of antihypertensive diuretic 
therapy in black South African patients with mild to moderate 
hypertension. Both study medications were well tolerated, with 
no serious adverse events or deaths observed. However, serum 
potassium levels should be monitored throughout therapy with 
both diuretics and potassium supplementation should be given 
where necessary. 
We have referred to black patients as this was our study 
population at Chris Hani-Baragwanath Hospital. Patients of 
African descent respond differently to Caucasians when given 
antihyperten:;ive medication, and this is well documented in the 
literature. As black patients suffer more from the effects of 
hypertension - end-stage renal failure, heart failure, etc. - it is 
important to determine causes and optimal treatment in this high-
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DIABETES IN RURAL SOUTH 
AFRICA- AN ASSESSMENT OF 
CARE AND COMPLICATIONS 
A P Rotchford, K M Rotchford 
Objectives. To describe the diabetic population under care of 
the public health sector in a district in rural KwaZulu-Natal, 
to assess the nature of their care, their glycaemic control 
and the extent of their complications. 
Subjects and methods. Two hundred and fifty-three diabetic 
patients consecutively attending clinics for review were 
interviewed and examined, and where available a 12-
month retrospective review of clinical records was 
performed. Random blood glucose, haemoglobin A1, 
(HbA1,) and urine albumin/ creatinine ratio were assayed. 
Results. Acceptable glycaemic control (HbA1, < 2% above 
normal population range) was found in only 15.7% of 
subjects (95% confidence interval (CI): 11.4- 20.8%). Mean 
HbA1, was 11.3%. The prevalence of hypertension (blood 
pressure~ 160/95 mmHg and/or prescribed antihyper-
tensive medication) was 65.4% (CI: 59.0 - 71.1 %). Of 129 
patients who were prescribed antihypertensives, 14.0% (CI: 
8.5- 21.2%) were normotensive(< 140/90 mmHg). Severe 
obesity was present in 36.5% (CI: 30.4- 42.9%). Rates of 
attendance for review and compliance with diabetic 
medications were high. Blood glucose monitoring was not 
regularly performed and medications were rarely modified. 
Complications were common and mostly undiagnosed. 
Retinopathy of any grade was found in 40.3% of patients 
(CI: 33.2- 50.9%) and was severe enough to warrant laser 
photocoagulation in 11.1% (CI: 8.5- 21.2%). 
Microalbuminuria was found in 46.4% (CI: 40.0 - 53.0%) 
and foot abnormalities attributable to diabetes in 6.0% (CI: 
3.4- 9.7%). 
Conclusions. Care and control of diabetes in this rural 
community is suboptimal. There is a need for primary care 
staff to focus on modifying prescriptions in the face of poor 
blood glucose control and/ or uncontrolled hypertension. 
Additional training and support for nursing staff and 
education for patients will be central to achieving this level 
of intervention. 
S Afr Med J 2002; 92: 536-541. 
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The World Health Organisation (WHO) estimates that there are 
150 million people with diabetes worldwide, a figure that is 
expected to double by the year 2025.1 Until recently it was 
considered to be rare in sub-Saharan Africa, but as a result of 
demographic and lifestyle changes, as well as increasing 
recognition, it is being identified as a major health problem.' In 
urbanised black populations in South Africa, recent surveys 
estimate the prevalence of diabetes at around 8% in those over 
30 years of age'·' and it is a major cause of mortality and 
morbidity.,_, 
Ongoing quality care is necessary to minimise the incidence 
and severity of acute and chronic complications. Evidence-
based standards of care and specific treatment targets centred 
on the long-term control of blood glucose and hypertension 
have been formulated' and adapted for the situation in South 
Africa.' However, the management of diabetes in the light of 
studies supporting intensive intervention is complex and 
delivering anything like ideal care presents enormous 
problems.10 This is especially true in rural areas where 
particular socioeconomic, cultural and geographical difficulties 
exist. So far, studies in South Africa have focused on urban 
diabetic populations3•7•11 and little is known about the quality of 
care and distribution of complications in rural communities. 
The aim of this study was to describe the diabetic population 
under the care of the government health sector in Hlabisa, a 
typical health district in rural KwaZulu-Natal, to assess the 
nature of the care they receive, the level of blood glucose 
control achieved and the extent of complications. 
SETTING 
Hlabisa district has a population of around 200 000, most living 
in scattered, rural homesteads. Prevalence data for total 
diabetes are not yet available in Hlabisa, or elsewhere in rural 
southern Africa. Electronic data linkage of lists from the 
hospital and peripheral clinics identified 302 registered patients 
(whole population crude prevalence rate of 0.2%)12 but a large 
majority almost certainly remain undiagnosed. 13 
Government health care is provided at a 300-bed district 
hospital. In addition there is a mobile clinic service, and 12 
permanent clinics staffed by nurses trained in primary health 
care and visited by a doctor on a monthly basis. The 
management of diabetes is nurse-led and centres on algorithms 
designed to be used by experienced primary care nurses to 
implement stepwise treatment for diabetes and concurrent 
hypertension.1' Patients are requested to attend each month. 
SUBJECTS AND METHODS 
Over a 2-month period in 1999, consecutive diabetic patients 
presenting for follow-up at the hospital and the district's 
permanent clinics were given their next appointment on one of 
a series of specific days as close to their normal monthly 
appointment as possible. This approach was calculated to 
maximise recruitment. 
Interview and record review 
Participants were interviewed by a single physician and a 
nurse translator using a structured protocol. Socio-
demographic data were recorded. Duration of diabetes and a 
history of diabetic complications and treatment were confirmed 
where possible by consulting patient-held records. The number 
of follow-up visits attended, abnormal clinical observations or 
biochemical results, medications and interventions in the 
previous 12 months were taken from the records. Patients were 
asked about their compliance with diabetic and hypertensive 
medications, using sample tablets for comparison. 
Examination 
Weight, height and blood pressure (BP) were measured by an 
experienced nurse. BP was measured at the right antecubital 
fossa, seated, using an appropriately sized cuff. Readings 
above 140/90 mmHg were repeated after 5 minutes and the 
lowest diastolic and systolic values recorded. 
Feet were examined by the physician for signs of ulceration, 
infection, amputation and absence of dorsalis pedis pulses. 
Peripheral neuropathy was not assessed. 
Visual acuity was measured using a Snellen chart at 6 m with 
distance correction if glasses were worn. Slit-lamp 
biomicroscopy of the anterior segment was performed by an 
ophthalmologist. Objective refraction by retinoscopy was 
performed in those with visual acuity< 6/18 and clear media. 
Indirect stereoscopic fundoscopy was performed at the slit-
lamp through dilated pupils. 
Biochemical tests 
Venous blood samples were taken for determination of 
albumin/ creatinine ratios, haemoglobin A1, (HbA1) and 
random blood glucose (RBG) levels. HbA1, was measured 
using a Roche Cobas Integra high-performance liquid 
chromatography assay (non-diabetic 95% reference range of 4.5 
- 5.7%, interassay coefficient of variation of 0.82%). Fresh urine 
samples were tested with reagent strips for the presence of 
proteinuria. 
Data management and statistical methods 
Double-entered data were stored in Epi Info 6 and analysed 
using Stata 6. Proportions are followed in parentheses by 95% 
exact binomial confidence intervals (Cis), unadjusted for 
sampling fraction. Chi-squared and Student's t-tests were used 
to test the significance of differences in discrete and continuous 
variables respectively. Predictors of chronic diabetic 
complications were examined by univariate analysis (X' testing) 
and stepwise multivariate logistic regression. 
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Definitions 
For the purposes of this study, type 1 diabetes was defined by 
onset of insulin dependency under 40 years of age or a history 
of ketoacidos.[s. All other patients with diabetes were labelled 
as type 2 even if they were insulin-treated. 
Patients receiving antihypertensive medication or with a 
repeat systolic BP ~ 160 mmHg or repeat diastolic BP 
~ 95 mmHg were defined as hypertensive. Borderline 
hypertension was diagnosed if BP ~ 140/90 mmHg but< 
160/95 mmHg."·16 
Obesity was defined as a body mass index (weight/height') 
above 27 kg/m' and severe obesity as above 33 kg/m'. 
Renal function was assessed using the urine albumin/ 
creatinine ratio. Microalbuminuria was defined as a value 
above 2.5 mg/mmol in men or 3.5 mg/mmol in women, and 
macroalbuminuria as a ratio~ 20 mg/mmoi.17 
Visual impairment was classified according to WHO and 
International Classification of Diseases (ICD)-10 definitions in 
which low vision was defined as a visual acuity< 6/18 but 
~ 3/60 in the better eye, and blindness was defined as a visual 
acuity <3/60 in the better eye.18 Diabetic retinopathy was 
classified and graded according to the guidelines of the Early 
Treatment Diabetic Retinopathy Study Research Group 
(ETDRS)/9•20 according to the findings in the most severely 
affected eye. 
RESULTS 
Demographic and social 
The study population consisted of 253 Zulu diabetic patients 
representing 83.8% of the registered diabetic population in the 
districtY The mean age ± standard deviation (SD) was 56.5 ± 
10.4 years (mnge 21 - 81 years), and 26.9% were male. The 
excess of females is an accurate reflection of the patients 
attending for chronic medical care in Hlabisa. 14 Of 68.4% of 
patients not old enough to receive an old-age pension, only 
12.7% were employed, 56.0% were unemployed and 27.7% 
received a state disability grant. The median years of schooling 
was 4 (interquartile range 0 - 7 years). 
Type and duration of diabetes 
Eighteen patients (7.1 %) were insulin-dependent (type 1) 
diabetic patients. Of the 235 (92.9%) non-insulin-dependent 
(type 2) subjects, 28 (11.9%) were insulin-treated and 3 (1.2%) 
were diet-controlled. The period since diagnosis displayed a 
log normal distribution with a geometrical mean of 4.2 years 
(range 6 weeks - 60 years). 
Glycaemk control 
HbA~c was assayed in 98.4% of the study population. The mean 
± SD was 11.3 ± 3.0% (range 5.2- 21.9%) A value within the 
normal population range (4.5 - 5.7%) was found in only 2 
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Fig. 1. Frequency distribution of HbA1,. 
patients and 84.3% (79.2- 88.6%) had an HbA1, over two 
percentage points above this upper limit. The frequency 
distribution is shown in Fig. 1. The mean HbA1, in patients 
with type 1 diabetes (11.9%) and type 2 diabetes (11.2%) were 
not significantly different (P = 0.32). The mean ± SD RBG was 
14.5 ± 7.5 mmol/1. A value below 4.0 mmol/1 was found in 
1.6% (0.4- 4.0%), and 66.3% (60.2- 72.2%) had a value over 10.0 
mmol/1. 
Hypertension 
Hypertension was present in 165 subjects (65.4%, 59.0- 71.1 %) 
of whom 78.2% (71.1 - 84.2%) were currently prescribed 
antihypertensive medications. Borderline hypertension was 
found in a further 40 subjects (15.8%). Among those prescribed 
antihypertensive medication, 14.0% (8.5- 21.2%) were 
normotensive (BP < 140/90 mmHg), 41.8% (33.2- 50.9%) had a 
BP ~ 140/90 mmHg but< 160/95 mmHg, and 44.2% (35.5-
53.2%) had a BP ~ 160/95 mmHg. Recent guidelines 
recommended a target BP < 130/85 mmHg for diabetic 
patients.'1•22 This target was only met in 19.8% (15.0- 25.2%) 
overall, and 10.1% (5.5 - 16.6%) of those on medication. 
Compliance with antihypertensive medication (reported 
taking medication in the previous 24 hours) was 61.2%. 
Compliance with diabetic medication 
Among both insulin-dependent and non-insulin-dependent 
patients, 94% reported having taken their medication in the 
previous 3 days. This extended period was chosen because it 
was known that some diabetic patients omit their medication 
on the day of clinic attendance. 
Body mass index 
The mean± SD body mass index (BMI) was 31.2 ± 6.9 kg/m 2 
(range 17.1 - 60.4 kg/m'). Obesity (BMI > 27 kg/m') was 
present in 63.0% of subjects (56.6- 69.2%), and 36.5% (30.4-
42.9%) were severely obese (BMI > 33 kg/m'). The mean was 
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significantly higher in women (32.0 kg/m') than men 
(29.1 kg/m2) (P = 0.003). 
Diabetic complications 
One hundred and seventeen subjects (46%) had been admitted 
to hospital on at least one occasion for a complication related to 
diabetes. 
Ophthalmic. Diabetic retinopathy of any grade was present 
in at least one eye of 40.3% (34.2- 46.6%) of the 251 subjects 
(99.2%) in whom fundoscopy was performed. The proportion 
in the small number of insulin-dependent patients (52.6%, 
28.9- 75.6%) was not significantly different (P = 0.18). The 
distribution according to the grade of retinopathy in the worse 
eye is given in Table I. In 5.6% of subjects (3.1 - 9.2%) 
retinopathy had progressed to the proliferative stage, with 
42.8% of those patients already blind or at high risk of severe 
visual loss in at least one eye." Macular oedema was found in 
16.2% (7.5- 15.7%) of patients, and in 103% (6.8- 14.7%) this 
was clinically significant.24 Overall, 11.1% (7.5- 15.6%) of 
patients required retinal photocoagulation to reduce their risk 
of progression to severe visual loss according to recommended 
guidelines.23•24 Pan-retinal photocoagulation had been 
performed in 3 of the 14 subjects with proliferative retinopathy, 
2 of whom required further treatment because of persistent 
retinal ischaemia. Four subjects were blind, 2 as a result of 
diabetic retinopathy. Visual impairment was found in 12.3% of 
subjects (8.5- 16.9%), the main contributors being cataract and 
refractive errors. 
Table I. Frequency of diabetic retinopathy by type and grade 
95% confidence 
Number % for% 
Nonproliferative 
Minimal 37 14.7 10.6- 19.7 
Moderate 34 13.5 9.6- 18.4 
Severe I v.severe 16 6.3 3.7- 10.1 
Proliferative 14 5.6 3.1 - 9.2 
Maculopathy 
All cases 41 16.2 11.9- 21.3 
Clinically significant 26 10.3 6.8- 14.7 
All retinopathy 102 40.3 34.2-46.6 
Renal. An elevated urine albumin/ creatinine ratio was 
present in 46.4% (40.0- 53.0%) of subjects and 13.4% (9.3-
18.4%) had macroalbuminuria. The reagent strip tests revealed 
proteinuria in 23.3% (18.0 - 29.4%) on the study day but we 
were unable to comment on the level of persistent proteinuria 
since too few patients had had repeated urine testing recorded 
in the notes. 
Peripheral vascular. Dorsalis pedis pulses were absent in 
16.6% of patients (12.2- 21.8%). Signs of foot ulceration or 
cellulitis were present in 6.0% (3.4- 9.7%) and 1 patient had 
had multiple surgical toe amputations. No cases of dry 
gangrene were seen. 
Cerebrovascular. A history consistent with cerebrovascular 
accident was elicited from 7.5% of subjects (4.6- 11.5%). 
Medical attention in the previous year 
Patient-held medical records were available for review in 236 
cases (93.3%). Among those who had been diagnosed and 
under local care for at least 12 months (90.2%), the mean 
number of visits ± SD in the previous year was 9.5 ± 3.4 (range 
1 - 18). BP was recorded at least once in 86.9% (81.9- 90.9%) of 
the sets of notes but monitoring of glycaemia was less frequent: 
47.6% (40.6- 54.6%) had no blood glucose recorded, 77.8% 
(72.1 - 82.8%) had no urine glucose monitoring and 43.7% 
(36.8 - 50.8%) had neither during the previous year. Only 7 
patients monitored their diabetes themselves at home. 
Among those with a recorded BP, 68.3% had at least one 
reading> 140/90 mmHg and 50.2% had two or more high 
recordings. In those with a recorded blood glucose reading, 
66.6% had at least one reading;::>: 17 mmol/1 and 32.5% had two 
or more. However, despite these abnormal results, few changes 
to medication were made. Of 118 cases with at least two 
abnormal BP or blood glucose readings only 28 had their 
medication altered (23.7%, 16.4- 32.4%). 
Six patients had had dilated fundoscopy recorded in the 
previous 12 months. 
Predictors of complications 
There was a strong tendency for coexistence of different forms 
of microangiopathy. Subjects with retinopathy were more likely 
to be microalbuminuric or macroalbuminuric (unadjusted odds 
ratios 4.2 (2.3 - 7.6) and 5.5 (2.3 - 13.4) respectively). 
On multivariate logistic regression, retinopathy was also 
found to be positively associated with increasing length of time 
since diagnosis, age, and HbA1" and negatively with increasing 
BML Those with diabetes diagnosed at least 5 years previously 
were at six times greater risk than more recently diagnosed 
patients, and those aged over 50 years were more than three 
times likely to have retinopathy than younger subjects. The 
significance of glycaemic control as measured by HbA1c as a 
risk factor for retinopathy was only marginal, although an 
isolated assay reflects mean glycaemia only for the last 2 
months. Women were nearly three times more at risk than men 
after adjusting for other factors, possibly reflecting increased 
vascular mortality in males. Increasing BMI was associated 
with a large reduction in risk- by a factor of five in the IIJD 
severely obese. No effect of hypertension or type of diabetes 
was apparent, although the small number of insulin-dependent 
patients is acknowledged. Details of the analysis are given in 
Table II. 
Risk factors for microalbuminuria as the outcome of interest 
were slightly different (Table III). The trend for increased risk 
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Table II. Risk factors for diabetic retinopathy 
Odds ratio 
No. of No. with (95% CI) from 
cases (%) retinopathy logistical P-
Predictors (N = 253) (%) (N = 102) regression* valuet 
Duration (yrs) 
$;5 130 (54.1) 30 (12.5) 
5-10 52 (21.7) 30 (57.7) 6.1 (2.7- 13.5) < 0.001 
> 10 58 (24.2) 37 (63.8) 6.0 (2.7- 13.0) < 0.001 
BMI (kg/m') 
527 65 (27.0) 37 (56.9) 
27-33 88 ( 36.5) 31 (35.6) 0.28 (0.12 - 0.64) 0.002 
>33 88 (36.5) 31 (35.2) 0.20 (0.08 - 0.48) < 0.001 
Age (yrs) 
$;so 67 (26.9) 17 (25.7) 
51-60 97 (39.0) 45 (46.9) 3.5 (1.5- 8.4) 0.004 
> 60 85 (34.1) 37 (43.5) 3.3 (1.3 - 8.1) 0.009 
HbA1, (%) 
$; 8.0 42 (16.9) 9 (22.5) 
8.1 - 11.0 77 (30.9) 34 (45.3) 2.9 (1.0- 8.1) 0.045 
11.1 -14.0 86 (34.5) 36 (41.9) 2.3 (0.82 - 6.4) 0.11 
> 14.0 44 07.7) 21 (47.7) 3.4 (1.1- 11.2) 0.041 
Gender 
Female 185 (73.1) 79 (43.6) 
Male 68 (26.9) 23 (33.8) 0.37 (0.17- 0.82) 0.014 
*Model contains duration of diabetes, body mass index (BMI), HbA~o, age and 
gender. No significant interaction terms; Odds ratios compared with first category as 
baseline. 
t Chi-squared te,,t, 
BMI = body maS!; index; CI :;: confidence interval. 
with longer duration and higher HbA1, is demonstrated, albeit 
only reaching significance for those diagnosed for more than 10 
years or in the worst category of glycaemic control. Severely 
obese subjects were nearly four times less likely to be 
microalbuminuric than those with normal BMI. Those with 
definite hypertension were at twofold increased risk compared 
with normotensives but age, gender and insulin dependence 
were not significant. 
DISCUSSION 
Glycaemia control in this group of rural patients was poor. 
Only 15.7% achieved the target level for HbA1, of < 2% above 
the normal population range set in national guidelines for 
managing diabetes in primary care." This compares badly with 
results from clinic-based studies not only in industrialised 
countries"~" but also elsewhere in Africa7'28 and places this 
population at significant risk of increased morbidity and 
liiDJ mortality. Contributing to this risk was the high proportion of 
patients with hypertension." Nearly two-thirds of subjects 
were hypertensive by our definition(::>: 160/95 mmHg or 
prescribed antihypertensive medication); however, a stricter 
target of< 130/85 mmHg is now widely recommended in 
diabeteS21 '22 and this was only met by 1 in 5 subjects. The 
proportion with hypertension is higher than reported in other 
diabetic populations.'-'5'29 This may in part be because of the 
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Table III. Risk factors for microalbuminuria 
Odds ratio 
No. of No. with micro- (95% CI) from 
cases(%) albuminuria logistical P-
Predictors (N = 253) (%) (N = 140) regression* valuet 
Duration (yrs) 
$;5 130 (54.1) 59 (45.0) 
5-10 52 (21.7) 30 (56.6) 1.49 (0.73 - 3.04) 0.27 
> 10 58 (24.2) 37 (76.7) 4.19 (1.93- 9.10) < 0.001 
BMI (kg/m') 
$; 27 65 (27.0) 45 (69.2) 
27-33 88 (36.5) 49 (55.7) 0.49 (0.22 - 1.09) 0.079 
> 33 88 (36.5) 39 (44.3) 0.27 (0.08 - 0.48) 0.002 
Age (yrs) 
$;50 67 (26.9) 38 (56.7) 
51-60 97 (39.0) 52 (53.6) 0.77 (0.37- 1.61) 0.50 
> 60 85 (34.1) 49 (57.6) 0.65 (0.29 - 1.44) 0.29 
HbA1, (%) 
$; 8.0 42 (16.9) 17 (40.5) 
8.1 -11.0 77 (30.9) 39 (50.6) 1.57 (0.66 - 3.73) 0.31 
11.1 - 14.0 86 (34.5) 49 (57.0) 1.99 (0.86- 4.64) 0.11 
> 14.0 44 (17.7) 32 (72.7) 4.69 (1.65 - 13.3) 0.004 
Hypertension 
No 88 (34.8) 96 (58.2) 
Yes 165 (65.2) 44 (50.0) 2.11 (1.07 - 4.17) 0.031 
* Model contains duration of diabetes, body mass index (BMI), HbA10 age and 
hypertension. No significant interaction terms. Odds ratios compared with first 
category as baseline. 
t Chi-squared test. 
BMl = body mass index, CI = confidence interval. 
'white coat' effect, as we only used readings on a single day, 
and an element of misdiagnosis in those on treatment cannot 
be discounted. But it may also be a reflection of the very high 
levels of obesity in South African type 2 diabetic patients7 
compared with elsewhere in Africa30 - two-thirds had a 
BMI > 27 kg/m'. 
The prevalence of chronic complications was also high. 
Retinopathy of any grade was found in 40.3% of subjects while 
in 11.1% the retinal appearance warranted laser 
photocoagulation. Few patients had undergone fundoscopic 
examination and nearly all retinopathy was previously 
undiagnosed. Nearly half of the subjects had evidence of renal 
damage in the form of a high albumin/creatinine ratio which is 
known to predict progression to renal failure.31 Foot 
abnormalities attributable to diabetes, including ulceration, 
sepsis and surgical amputation were found in 6%. 
Several independent risk factors for developing 
microvascular complications reported in non-Africans"'"~'' were 
confirmed, most notably duration of diabetes. A strong 
negative association was found with increasing BMI, a similar 
finding to that reported in Hong Kong and Zambia'0'36 for 
nephropathy and neuropathy. It is possible that this could 
reflect confounding by socioeconomic status, on which we did 
not collect data, or alternatively it may represent residual 
confounding from the effect of poor glycaemia control since 
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hyperglycaemia is known to result in weight loss as well as 
microvascular disease. A single assay for HbA1, as performed 
in this study does not necessarily reflect control over several 
years. 
Reported microvascular complication prevalences in sub-
Saharan Africa have varied widely.'·6•7•30•37·39 This may be partly a 
result of different diagnostic criteria, duration of disease and 
selection biases inherent in this type of prevalence study. 
Attendance at diabetic clinics is dependent on motivation, 
resources and mobility and as a result this type of study is 
likely to over-represent the wealthier, better-educated and least 
disabled of diabetics in the community. These complication 
rates also reflect survival. Mortality is high in African diabetes40 
and many patients may die before developing complications or 
die prematurely as a result of them. 
The study attempted to identify causes of poor diabetic 
control. Patient compliance was good, reflected by clinic 
attendance for review, and knowledge of and adherence to 
prescribed treatment. Several areas of service provision were 
suboptimal. Local guidelines do not encourage regular blood 
glucose monitoring in the clinic, but even where this was 
performed very few results were acted upon. Similarly, 
although most patients had their BP monitored, few of those 
with repeated high readings had had their treatment modified. 
As a result, the majority of patients remain inadequately 
treated. 
Diabetes has been targeted as a disease requiring special 
attention in South Africa and the importance of a community-
based primary care approach has been emphasised. This study 
demonstrates that there is still a long way to go to achieve 
acceptable standards of care for diabetic patients in this rural 
community. There is a need for health care workers to focus on 
implementing existing protocols particularly with regard to 
changing prescribing in the light of evidence of poor blood 
glucose control. Additional training and support for nursing 
staff and education for patients41 will be central to achieving 
this and a specialist nurse educator is to be introduced in the 
district to try to co-ordinate this. 
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